笔辞蝉迟罢颈尘别：9/12/2016
Recently, according to the news from STU-Technion Research Project Center, six research projects on human health, which are carried out by scholars and researchers from both STU and Technion, have been funded by the Li Ka-Shing Foundation. They are:
1.??? Identification of the Ubiquitin Ligase for Notch 3 Intracellular Domain: Implications for Tumor Suppression and Drug Development – Pro. Aaron Ciechanover & Pro. Zhang Guojun
2.??? The interplay between mitochondrial dysfunction, dopaminergic hyperactivity and hypomyelination in the brain: implications for schizophrenia – Pro. Dorit Ben-Shachar & Pro. Xu Haiyun
3.??? The heparanase-CD24-L1CAM axis in glioma tumorigenesis – Pro. Vlodavsky & Pro. Yang Xiaojun
4.??? Defining the Sharpin/PTPRO/PRMT5 regulatory axis in esophageal and melanoma cancers – Pro. Ze'ev Ronai & Pro. Zhang Hao
5.??? The association of common Genetic variants among populations of the "Esophageal cancer belt of Asia" and Squamous Esophageal Carcinoma – Pro. Stavit A. Shalev & Pro. Moshe Marom & Pro. Su Min
6.??? The Role Of Non-Secreted, Enzymatically Inactive Isoforms Of Loxl2 In Tumor Progression – Pro. Gera Neufeld & Pro. Li Enmin
?
Since the launch of STU-Technion Research Project, the Center has received twelve project proposals. So far, the fund has been allocated by the Li Ka-Shing Foundation, which will be available to the researchers in the near future.
?
The program was initiated by Dr. Frieda Law from the Li Ka-Shing Foundation and a physician in the medical school of Shantou University, and Prof. Aaron Ciechanover, the 2004 Nobel Laureate in Chemistry who serves also as Vice Chancellor of GTIIT.?
© GUANGDONG TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY |
